ArticleCancer research2018
ErbB3 Targeting Enhances the Effects of MEK Inhibitor in Wild-Type BRAF/NRAS Melanoma.
Claudia Capparelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleCancer research2018
Claudia Capparelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.